Developing advanced endoscopes for better cancer imaging in the GI tract
Official title: Endoscope development for the clinical use of near infrared fluorescence molecular probes in the GI tract
Funded at Veravanti, INC. · NIH-10493360 · Data updated 2026-11-12
This study is testing a new kind of endoscope that uses special light to help doctors see and treat esophageal cancer better, which could lead to earlier detection and more effective treatments for patients.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veravanti, INC. NIH-funded |
| Lab location | 1 site (Redmond, United States) |
| Project start | September 23, 2021 |
| Project end | August 31, 2025 |
| Funding year | 2022 |
| Award (this year) | $1,002,190 |
| NIH project number | 5R44CA261318-02 |
| Project ID | NIH-10493360 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for esophageal cancer, including those with Barrett's esophagus or other related conditions.
✕Less likely to help
Patients with no history of esophageal conditions or those who are not at risk for esophageal cancer may not benefit from this research.
What this research studies
This research focuses on creating a new type of endoscope that uses advanced optical imaging techniques to improve the detection and treatment of esophageal cancer. By utilizing near-infrared fluorescence molecular probes, the endoscope aims to enhance the visibility of cancerous tissues during procedures. The technology combines multiple laser wavelengths to provide detailed imaging, which can assist doctors in making more accurate diagnoses and guiding biopsies. Patients may benefit from earlier detection of cancer and more effective treatment options through this innovative approach.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and improved treatment outcomes for patients with esophageal cancer.
How similar studies have gone: Other research has shown promise in using advanced imaging techniques for cancer detection, indicating that this approach could be effective.
Where this research is happening
-
Veravanti, INC.
Redmond, United States Active
Researchers
- Principal investigator: Mcmorrow, Gerald — Veravanti, INC.
- Study coordinator: Mcmorrow, Gerald
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.